logo
#

Latest news with #NB.1.81

Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects
Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects

Time of India

time3 days ago

  • Health
  • Time of India

Trump administration cuts $766 million in funding to Moderna for bird flu, pandemic vaccine projects

(Representative image AP) The Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company responsible for developing vaccines. Moderna was tasked to make vaccines against potential pandemic influenza viruses, as well as the H5N1 bird flu. The Health and Human Services Department had notified the company on Monday about the withdrawal of funds that were awarded through the BARDA (Biomedical Advanced Research and Development Authority) program. HHS is withdrawing funds awarded in January and July this year, intended to finance the development and purchase of the company's investigational vaccine. Moderna had received $590 million in January and $176 million in July in funding meant to help judge the efficacy of the vaccines for bird flu and other pandemic viruses, as said by a company Spokesperson. Health secretary Robert F. Kennedy has expressed his concerns regarding the company's vaccines despite evidence that vaccines developed by Moderna are safe and have saved millions of lives before. 'While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis," said the company in a statement as reported by AP. Using the same technology used to develop and roll out vaccines during the Covid-19 pandemic, Moderna has developed a new vaccine called mRNA-1018. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Ida y vuelta a España desde 589$ Plus Ultra Compra ahora Undo On the other hand, a new, highly contagious variant of Covid-19 has surfaced in the US known as NB. 1.81. Initially detected in late March and early April among international travelers, cases have since been identified in New York, Ohio, California, Rhode Island, Hawaii, Washington State, and Virginia. Last year, the H5N1 bird flu virus spilled from wild birds into cattle and ended up infecting hundreds of animals across several states. 70 people reported sick with the flu, and one person died. Scientists have warned that continued alteration or evolution in the virus can make it more potent and ultimately lead to a pandemic.

'Should not be taken lightly': Highly contagious Covid-19 variant from China detected in US
'Should not be taken lightly': Highly contagious Covid-19 variant from China detected in US

Time of India

time3 days ago

  • Health
  • Time of India

'Should not be taken lightly': Highly contagious Covid-19 variant from China detected in US

This is a representative AI image A new, highly contagious strain of Covid-19 that has driven a wave of hospitalisations across China has now surfaced in the United States, including cases in New York City, federal health officials confirmed this week. Known as NB.1.81, the variant was first detected in US between late March and early April among international travellers arriving at airports in California, Washington State, Virginia, and New York. Additional cases have since been identified in Ohio, Rhode Island, and Hawaii, according to the centres for disease control and prevention (CDC). Though current numbers remain low in the US, public health experts are warning that the variant's rapid spread across Asia may foreshadow a new wave of infections. 'It appears to have a growth advantage, suggesting it may spread more easily,' said Subhash Verma, a microbiologist at the University of Nevada. NB.1.81 became the dominant strain in China earlier this year, prompting a noticeable surge in Covid-related emergency room visits and hospitalisations. In Hong Kong, officials reported the highest number of cases in over a year, with 81 severe infections and 30 deaths, mostly among those aged 65 and older, recorded in the past four weeks. Mainland China has also seen Covid-related ER visits more than double, from 7.5% to over 16% of all patients. Hospital admissions rose by more than 6%, according to local health authorities. Despite the rise in hospitalisations, Chinese and Hong Kong officials have downplayed the threat, insisting the variant is not more dangerous than previous strains. However, health experts remain cautious. 'What they're seeing in China, Hong Kong, and other regions is clearly a spike in hospitalisations,' said Dr Amy Edwards, a pediatric infectious disease expert at Case Western Reserve University. 'That's not something we can ignore.' US airport surveillance has revealed that the variant has travelled with infected individuals passing through countries including Japan, South Korea, France, Thailand, Vietnam, and the Netherlands, highlighting its global reach. The variant causes typical Covid symptoms—sore throat, cough, fatigue, and fever—but scientists are concerned about its ability to partially evade existing vaccine protections. Dr Edwin Tsui, head of Hong Kong's Centre for Health Protection, warned that NB.1.81 should not be taken lightly, citing 'early signs of vaccine mismatch.' The CDC, meanwhile, is adjusting its guidance. On Tuesday, it announced it would no longer recommend Covid vaccines for healthy children and pregnant women. The Trump administration has also signalled plans to restrict booster shots to only high-risk groups, such as seniors. As scientists track the variant's behaviour and transmissibility, experts urge caution and renewed attention to public health measures. 'It may not be more severe, but its ability to spread faster means we could see more cases and more hospitalisations if we're not prepared,' said Dr Edwards.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store